Recent Finacing
Recent Raise
Pleco Therapeutics is a clinical-stage specialty biopharmaceutical developing Plecoid chelating agents that remove toxic metals and modulate tumor microenvironment; advancing PTX-061 for AML and preclinical SCLC.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Pleco Therapeutics.
